| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chronic Pain | 14 | 2023 | 127 | 4.730 |
Why?
|
| Analgesics, Opioid | 11 | 2022 | 243 | 2.090 |
Why?
|
| Acupuncture Therapy | 7 | 2019 | 35 | 1.730 |
Why?
|
| Humans | 86 | 2023 | 17707 | 1.330 |
Why?
|
| Physician-Patient Relations | 4 | 2019 | 185 | 1.280 |
Why?
|
| Binge-Eating Disorder | 7 | 2020 | 13 | 1.250 |
Why?
|
| Telemedicine | 3 | 2023 | 185 | 1.210 |
Why?
|
| Musculoskeletal Pain | 4 | 2017 | 27 | 1.160 |
Why?
|
| Physicians, Primary Care | 4 | 2019 | 71 | 1.150 |
Why?
|
| Research Design | 11 | 2021 | 372 | 1.090 |
Why?
|
| Health Behavior | 7 | 2012 | 360 | 1.000 |
Why?
|
| Weight Loss | 6 | 2014 | 305 | 1.000 |
Why?
|
| Complementary Therapies | 4 | 2019 | 46 | 0.980 |
Why?
|
| Depressive Disorder | 9 | 2018 | 220 | 0.980 |
Why?
|
| Female | 61 | 2022 | 12729 | 0.940 |
Why?
|
| Obesity | 12 | 2013 | 841 | 0.890 |
Why?
|
| Health Promotion | 5 | 2013 | 280 | 0.870 |
Why?
|
| Adolescent | 36 | 2021 | 3671 | 0.870 |
Why?
|
| Delivery of Health Care, Integrated | 4 | 2019 | 531 | 0.840 |
Why?
|
| Smartphone | 2 | 2020 | 11 | 0.820 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2023 | 327 | 0.800 |
Why?
|
| Bulimia | 3 | 2011 | 8 | 0.800 |
Why?
|
| Serotonin Uptake Inhibitors | 9 | 2013 | 71 | 0.780 |
Why?
|
| Male | 49 | 2022 | 10094 | 0.760 |
Why?
|
| Practice Patterns, Physicians' | 6 | 2022 | 324 | 0.750 |
Why?
|
| Informed Consent | 1 | 2021 | 20 | 0.750 |
Why?
|
| Health Maintenance Organizations | 9 | 2015 | 414 | 0.720 |
Why?
|
| Primary Health Care | 8 | 2022 | 756 | 0.710 |
Why?
|
| Medicaid | 1 | 2022 | 188 | 0.700 |
Why?
|
| Self Care | 7 | 2017 | 164 | 0.700 |
Why?
|
| Students | 5 | 2013 | 54 | 0.700 |
Why?
|
| Depressive Disorder, Major | 7 | 2016 | 123 | 0.660 |
Why?
|
| Life Style | 3 | 2012 | 332 | 0.650 |
Why?
|
| Manipulation, Chiropractic | 3 | 2017 | 21 | 0.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2013 | 755 | 0.630 |
Why?
|
| Exercise | 6 | 2013 | 496 | 0.610 |
Why?
|
| Cyclohexanols | 8 | 2013 | 36 | 0.610 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2014 | 64 | 0.590 |
Why?
|
| Overweight | 5 | 2014 | 270 | 0.590 |
Why?
|
| Middle Aged | 28 | 2022 | 7976 | 0.590 |
Why?
|
| United States | 15 | 2022 | 3914 | 0.580 |
Why?
|
| Adult | 30 | 2021 | 7658 | 0.570 |
Why?
|
| Feeding Behavior | 5 | 2010 | 166 | 0.540 |
Why?
|
| Propensity Score | 1 | 2017 | 85 | 0.530 |
Why?
|
| Internet | 5 | 2012 | 229 | 0.520 |
Why?
|
| Antidepressive Agents | 5 | 2018 | 153 | 0.520 |
Why?
|
| Opioid-Related Disorders | 4 | 2021 | 165 | 0.510 |
Why?
|
| Chiropractic | 1 | 2016 | 10 | 0.510 |
Why?
|
| Adolescent Behavior | 3 | 2013 | 127 | 0.510 |
Why?
|
| Feeding and Eating Disorders | 3 | 2010 | 17 | 0.500 |
Why?
|
| Patient Selection | 5 | 2012 | 190 | 0.490 |
Why?
|
| Suicide | 3 | 2012 | 124 | 0.480 |
Why?
|
| Pragmatic Clinical Trials as Topic | 4 | 2020 | 61 | 0.450 |
Why?
|
| Child | 14 | 2018 | 2481 | 0.450 |
Why?
|
| Bulimia Nervosa | 4 | 2010 | 10 | 0.450 |
Why?
|
| Retrospective Studies | 10 | 2022 | 2471 | 0.430 |
Why?
|
| Mexican Americans | 1 | 2013 | 45 | 0.420 |
Why?
|
| Stress, Psychological | 3 | 2012 | 140 | 0.420 |
Why?
|
| Electronic Health Records | 7 | 2020 | 694 | 0.420 |
Why?
|
| Schools | 3 | 2011 | 87 | 0.420 |
Why?
|
| Cost-Benefit Analysis | 5 | 2023 | 243 | 0.400 |
Why?
|
| Oregon | 9 | 2019 | 187 | 0.400 |
Why?
|
| Diet | 3 | 2013 | 367 | 0.400 |
Why?
|
| Combined Modality Therapy | 9 | 2017 | 146 | 0.390 |
Why?
|
| Program Development | 3 | 2011 | 68 | 0.390 |
Why?
|
| Young Adult | 11 | 2021 | 2450 | 0.380 |
Why?
|
| Treatment Outcome | 10 | 2017 | 1254 | 0.380 |
Why?
|
| Health Services Research | 3 | 2015 | 213 | 0.380 |
Why?
|
| Child of Impaired Parents | 3 | 2013 | 33 | 0.380 |
Why?
|
| Social Marketing | 2 | 2010 | 13 | 0.370 |
Why?
|
| Physical Fitness | 1 | 2011 | 73 | 0.370 |
Why?
|
| Back Pain | 2 | 2022 | 33 | 0.350 |
Why?
|
| Surveys and Questionnaires | 9 | 2020 | 1322 | 0.340 |
Why?
|
| Attitude to Health | 4 | 2010 | 159 | 0.340 |
Why?
|
| Bone Density | 2 | 2008 | 97 | 0.330 |
Why?
|
| Aged | 12 | 2020 | 6150 | 0.330 |
Why?
|
| Body Mass Index | 10 | 2014 | 970 | 0.320 |
Why?
|
| Psychotropic Drugs | 4 | 2004 | 36 | 0.320 |
Why?
|
| Delivery of Health Care | 4 | 2017 | 397 | 0.310 |
Why?
|
| Self-Help Groups | 3 | 2017 | 29 | 0.300 |
Why?
|
| Adolescent Health Services | 3 | 2012 | 42 | 0.300 |
Why?
|
| Communication | 4 | 2021 | 191 | 0.290 |
Why?
|
| Biomedical Research | 2 | 2019 | 82 | 0.290 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2008 | 3 | 0.280 |
Why?
|
| Patient Satisfaction | 4 | 2019 | 204 | 0.280 |
Why?
|
| School Health Services | 2 | 2013 | 39 | 0.270 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 1218 | 0.270 |
Why?
|
| Antidepressive Agents, Second-Generation | 3 | 2011 | 28 | 0.270 |
Why?
|
| Quality of Life | 4 | 2023 | 521 | 0.260 |
Why?
|
| Pain | 2 | 2019 | 79 | 0.260 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 10 | 0.260 |
Why?
|
| Patient-Centered Care | 2 | 2019 | 194 | 0.250 |
Why?
|
| Mental Health Services | 2 | 2004 | 154 | 0.240 |
Why?
|
| Prevalence | 7 | 2019 | 882 | 0.240 |
Why?
|
| Patient Education as Topic | 3 | 2018 | 212 | 0.230 |
Why?
|
| Health Communication | 2 | 2016 | 16 | 0.230 |
Why?
|
| Qualitative Research | 4 | 2018 | 257 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2009 | 387 | 0.220 |
Why?
|
| Osteoporosis | 1 | 2004 | 78 | 0.220 |
Why?
|
| Venlafaxine Hydrochloride | 8 | 2013 | 37 | 0.220 |
Why?
|
| Prospective Studies | 3 | 2022 | 1287 | 0.220 |
Why?
|
| Craniofacial Abnormalities | 1 | 2003 | 7 | 0.210 |
Why?
|
| Fluoxetine | 5 | 2013 | 26 | 0.210 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2013 | 14 | 0.210 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2003 | 33 | 0.200 |
Why?
|
| Weight Gain | 3 | 2014 | 175 | 0.200 |
Why?
|
| Nurse's Role | 1 | 2022 | 7 | 0.200 |
Why?
|
| Depression | 5 | 2022 | 504 | 0.200 |
Why?
|
| Pain Management | 3 | 2018 | 57 | 0.190 |
Why?
|
| Public Health | 2 | 2019 | 81 | 0.190 |
Why?
|
| Managed Care Programs | 3 | 2010 | 313 | 0.190 |
Why?
|
| Policy | 1 | 2022 | 18 | 0.190 |
Why?
|
| Anxiety | 1 | 2013 | 152 | 0.190 |
Why?
|
| Paroxetine | 4 | 2013 | 23 | 0.190 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 10 | 0.190 |
Why?
|
| Acupressure | 2 | 2012 | 5 | 0.180 |
Why?
|
| Mood Disorders | 1 | 2001 | 18 | 0.180 |
Why?
|
| Community Health Centers | 1 | 2022 | 65 | 0.180 |
Why?
|
| Pharmacy | 1 | 2021 | 12 | 0.180 |
Why?
|
| Parents | 2 | 2013 | 295 | 0.180 |
Why?
|
| Community Mental Health Services | 1 | 2001 | 32 | 0.180 |
Why?
|
| Yoga | 1 | 2021 | 26 | 0.180 |
Why?
|
| Meditation | 1 | 2021 | 20 | 0.180 |
Why?
|
| Mindfulness | 1 | 2021 | 27 | 0.170 |
Why?
|
| Self-Management | 1 | 2020 | 29 | 0.170 |
Why?
|
| Behavior Therapy | 2 | 2012 | 144 | 0.170 |
Why?
|
| Health Care Surveys | 2 | 2016 | 223 | 0.170 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 12 | 0.170 |
Why?
|
| Mentoring | 1 | 2020 | 26 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 314 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 7 | 2011 | 123 | 0.160 |
Why?
|
| Neck Pain | 1 | 2019 | 12 | 0.160 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 85 | 0.150 |
Why?
|
| Interviews as Topic | 1 | 2019 | 301 | 0.150 |
Why?
|
| Citalopram | 3 | 2013 | 14 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 10 | 0.150 |
Why?
|
| Comorbidity | 4 | 2013 | 590 | 0.150 |
Why?
|
| Washington | 4 | 2020 | 382 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2018 | 16 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 2 | 2014 | 137 | 0.150 |
Why?
|
| Child, Preschool | 5 | 2014 | 1417 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 151 | 0.140 |
Why?
|
| Northwestern United States | 4 | 2021 | 53 | 0.140 |
Why?
|
| Information Dissemination | 1 | 2017 | 50 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2015 | 1322 | 0.140 |
Why?
|
| Weight Reduction Programs | 3 | 2012 | 52 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2012 | 299 | 0.130 |
Why?
|
| Time Factors | 4 | 2012 | 1095 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2009 | 381 | 0.130 |
Why?
|
| Case Management | 1 | 2016 | 32 | 0.130 |
Why?
|
| Insurance, Health | 1 | 2017 | 175 | 0.120 |
Why?
|
| Activities of Daily Living | 3 | 2011 | 85 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2016 | 165 | 0.110 |
Why?
|
| Cholesterol, VLDL | 1 | 2014 | 2 | 0.110 |
Why?
|
| Particle Size | 1 | 2014 | 4 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2021 | 215 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 27 | 0.110 |
Why?
|
| Incidence | 3 | 2010 | 1269 | 0.110 |
Why?
|
| Morphine | 1 | 2013 | 8 | 0.110 |
Why?
|
| Manuals as Topic | 2 | 2010 | 7 | 0.110 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 81 | 0.110 |
Why?
|
| Psychotherapy, Group | 2 | 2013 | 25 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 119 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 154 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 616 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2014 | 155 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 448 | 0.100 |
Why?
|
| Drug Resistance | 4 | 2011 | 31 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 30 | 0.100 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 85 | 0.100 |
Why?
|
| Mind-Body Therapies | 1 | 2012 | 9 | 0.100 |
Why?
|
| Social Support | 2 | 2012 | 204 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 34 | 0.100 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 128 | 0.100 |
Why?
|
| Persuasive Communication | 1 | 2011 | 3 | 0.100 |
Why?
|
| Risk Factors | 6 | 2014 | 3367 | 0.090 |
Why?
|
| Disclosure | 1 | 2011 | 17 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 55 | 0.090 |
Why?
|
| Drug Utilization | 2 | 2003 | 124 | 0.090 |
Why?
|
| Peer Group | 1 | 2011 | 49 | 0.090 |
Why?
|
| Suicide, Attempted | 2 | 2009 | 99 | 0.090 |
Why?
|
| Pediatrics | 1 | 2012 | 156 | 0.090 |
Why?
|
| Pharmacists | 2 | 2021 | 50 | 0.090 |
Why?
|
| Sleep | 1 | 2011 | 58 | 0.090 |
Why?
|
| Biomarkers | 2 | 2014 | 312 | 0.090 |
Why?
|
| Focus Groups | 2 | 2017 | 146 | 0.080 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2009 | 2 | 0.080 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2011 | 227 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2009 | 12 | 0.080 |
Why?
|
| Curriculum | 1 | 2009 | 36 | 0.080 |
Why?
|
| Culture | 1 | 2009 | 26 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2018 | 38 | 0.080 |
Why?
|
| Eating | 1 | 2009 | 37 | 0.080 |
Why?
|
| Retention (Psychology) | 1 | 2008 | 7 | 0.080 |
Why?
|
| Calcium | 1 | 2008 | 35 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2010 | 222 | 0.080 |
Why?
|
| Facial Pain | 1 | 2008 | 5 | 0.080 |
Why?
|
| Naturopathy | 1 | 2008 | 5 | 0.080 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2008 | 7 | 0.080 |
Why?
|
| Self-Injurious Behavior | 1 | 2009 | 45 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 379 | 0.070 |
Why?
|
| Health Surveys | 3 | 2018 | 260 | 0.070 |
Why?
|
| Remission Induction | 2 | 2013 | 26 | 0.070 |
Why?
|
| Logistic Models | 3 | 2011 | 918 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 131 | 0.070 |
Why?
|
| Osteocalcin | 1 | 2006 | 4 | 0.070 |
Why?
|
| Ethnic Groups | 1 | 2010 | 474 | 0.070 |
Why?
|
| Naltrexone | 1 | 2006 | 15 | 0.070 |
Why?
|
| Diet Surveys | 1 | 2006 | 57 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2014 | 2589 | 0.070 |
Why?
|
| Health Services | 1 | 2007 | 114 | 0.070 |
Why?
|
| Diet, Reducing | 3 | 2011 | 25 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2021 | 111 | 0.060 |
Why?
|
| Personality Inventory | 2 | 2010 | 14 | 0.060 |
Why?
|
| Psychometrics | 3 | 2010 | 122 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 371 | 0.060 |
Why?
|
| Mass Screening | 1 | 2010 | 667 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2015 | 416 | 0.060 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2004 | 102 | 0.060 |
Why?
|
| Health Education | 1 | 2004 | 110 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 4 | 0.050 |
Why?
|
| Family Relations | 1 | 2003 | 16 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 198 | 0.050 |
Why?
|
| Social Class | 1 | 2003 | 121 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 1927 | 0.050 |
Why?
|
| Linear Models | 2 | 2014 | 229 | 0.040 |
Why?
|
| Anorexia Nervosa | 2 | 2010 | 5 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 2010 | 11 | 0.040 |
Why?
|
| Physical Education and Training | 1 | 2010 | 19 | 0.040 |
Why?
|
| Health Policy | 1 | 2001 | 118 | 0.040 |
Why?
|
| Secondary Prevention | 2 | 2010 | 48 | 0.040 |
Why?
|
| Child Health Services | 1 | 2001 | 106 | 0.040 |
Why?
|
| Body Weight | 2 | 2012 | 226 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2010 | 35 | 0.040 |
Why?
|
| Body Image | 2 | 2010 | 21 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 115 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 286 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 108 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 132 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 11 | 0.040 |
Why?
|
| Insulin | 1 | 2010 | 213 | 0.040 |
Why?
|
| Veterans | 1 | 2020 | 137 | 0.040 |
Why?
|
| Integrative Medicine | 1 | 2019 | 8 | 0.040 |
Why?
|
| Infant | 1 | 2003 | 1199 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2010 | 348 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 20 | 0.040 |
Why?
|
| Telephone | 2 | 2012 | 161 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2001 | 276 | 0.040 |
Why?
|
| Health Personnel | 1 | 2019 | 123 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 27 | 0.040 |
Why?
|
| Research Report | 1 | 2017 | 23 | 0.040 |
Why?
|
| Confidentiality | 1 | 2017 | 25 | 0.040 |
Why?
|
| Recurrence | 2 | 2010 | 189 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 75 | 0.030 |
Why?
|
| Prognosis | 1 | 2009 | 613 | 0.030 |
Why?
|
| Allied Health Personnel | 1 | 2017 | 12 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2016 | 33 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 182 | 0.030 |
Why?
|
| Caregivers | 1 | 2017 | 128 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 89 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 5 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 88 | 0.030 |
Why?
|
| Thinness | 1 | 2014 | 32 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2013 | 16 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 45 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2014 | 296 | 0.030 |
Why?
|
| Adolescent Medicine | 1 | 2012 | 3 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2012 | 48 | 0.030 |
Why?
|
| Acupuncture Points | 1 | 2012 | 3 | 0.020 |
Why?
|
| Mental Processes | 1 | 2012 | 3 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 670 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2012 | 69 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2014 | 241 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 222 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 29 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 159 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2012 | 39 | 0.020 |
Why?
|
| Computers | 1 | 2011 | 6 | 0.020 |
Why?
|
| Television | 1 | 2011 | 22 | 0.020 |
Why?
|
| Psychopathology | 1 | 2010 | 4 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2010 | 15 | 0.020 |
Why?
|
| Cost Savings | 1 | 2010 | 22 | 0.020 |
Why?
|
| Indians, North American | 1 | 2010 | 49 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 100 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 63 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 227 | 0.020 |
Why?
|
| Food | 1 | 2009 | 31 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2009 | 20 | 0.020 |
Why?
|
| Self Concept | 1 | 2009 | 39 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 2009 | 12 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2009 | 29 | 0.020 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2008 | 6 | 0.020 |
Why?
|
| Hispanic Americans | 1 | 2010 | 397 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 1106 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2010 | 523 | 0.020 |
Why?
|
| African Americans | 1 | 2010 | 465 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 639 | 0.020 |
Why?
|
| Office Visits | 1 | 2007 | 77 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 59 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 90 | 0.020 |
Why?
|
| Cues | 1 | 2005 | 10 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 596 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 237 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 311 | 0.010 |
Why?
|